WeVote

Bill

Bill

HD 2589

An Act relative to increasing access to epinephrine

194th Legislature (2025-2026) Introduced by Thomas Moakley

Massachusetts bill expands emergency epinephrine access to untrained personnel in public settings, improving anaphylaxis response times but raising liability and training concerns.

0
WeVote Research Nonpartisan
Bill Summary · HD 2589

Legislative bill overview

HD 2589 aims to expand public access to epinephrine (a medication for severe allergic reactions) by allowing non-medical personnel to obtain and administer it in emergency situations. The bill likely removes barriers to epinephrine availability in schools, workplaces, and public spaces, and may establish legal protections for untrained individuals who administer the drug during anaphylaxis emergencies.

Why is this important

Anaphylaxis can be fatal within minutes, and early epinephrine administration significantly improves survival rates. Currently, access restrictions and liability concerns may delay treatment in emergencies, particularly in settings without medical professionals present. Broadening access could save lives by ensuring epinephrine is available when and where allergic emergencies occur.

Potential points of contention

  • Liability and oversight: Questions about legal responsibility if untrained personnel administer epinephrine incorrectly or in inappropriate situations
  • Storage and maintenance: Concerns about proper storage, expiration dates, and inventory management in non-medical settings
  • Training requirements: Debate over whether some training should be mandated versus making the drug available without prerequisites, and how to balance accessibility with safe use

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.